Encompass Health: Vanguard Holds 5.23M Shares

Encompass Health Corp reports beneficial ownership of 5,233,622 shares of Common Stock, representing 5.26% of the class as of 03/31/2026.

Rhea-AI Filing Summary

Encompass Health Corp reports beneficial ownership of 5,233,622 shares of Common Stock, representing 5.26% of the class as of 03/31/2026. The filing attributes sole voting power for 767,385 shares and sole dispositive power over 5,233,622 shares to Vanguard Capital Management and certain affiliates under SEC Release No. 34-39538.

Insights

Institutional Ownership Analyst

Vanguard holds a modest >5% stake in Encompass Health.

Vanguard Capital Management reports beneficial ownership of 5,233,622 shares (5.26%) as of 03/31/2026. The filing shows sole dispositive power over the full stake and sole voting power for 767,385 shares, consistent with asset-manager aggregated reporting.

This is a standard Schedule 13G disclosure for an institutional investor; subsequent trading activity or amendments would appear in later filings.

Corporate Governance Specialist

Aggregated reporting clarifies which Vanguard entities exercise control.

The submission names Vanguard Capital Management and affiliates that exercise dispositive or voting power under SEC Release No. 34-39538, and confirms no other single person holds >5% of the reported shares.

Shareholders and boards often review such 13G filings when tracking institutional ownership trends; timing and any changes will be shown in future amendments.

Key Figures

Shares beneficially owned: 5,233,622 shares Percent of class: 5.26% Sole voting power: 767,385 shares +2 more

5 metrics

Shares beneficially owned 5,233,622 shares Beneficial ownership as reported

Percent of class 5.26% Percentage of common stock reported

Sole voting power 767,385 shares Sole power to vote or direct the vote

Sole dispositive power 5,233,622 shares Sole power to dispose or direct disposition

Reporting date 03/31/2026 Ownership as of date shown in filing

Key Terms

Schedule 13G, Beneficially owned, Dispositive power

3 terms

Schedule 13G regulatory

"Name of form: SCHEDULE 13G reporting beneficial ownership"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"reflects the securities beneficially owned, or deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 5233622"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Encompass Health (EHC) shares does Vanguard own?

Vanguard reports beneficial ownership of 5,233,622 shares. The Schedule 13G states this equals 5.26% of Encompass Health's common stock as of 03/31/2026. The filing aggregates holdings across Vanguard Capital Management and specified affiliates under SEC guidance.

Does Vanguard control the voting rights for its Encompass Health stake?

Vanguard has sole voting power for 767,385 shares. The filing lists sole dispositive power over 5,233,622 shares and sole voting power for 767,385, with no shared voting or dispositive powers reported in this submission.

What does Schedule 13G filing by Vanguard mean for EHC investors?

It discloses institutional ownership exceeding 5% without activist intent. Schedule 13G typically signals passive or index-related holdings; the filing lists exact shares and voting/dispositive powers but does not indicate any change in strategy or control actions.

When was Vanguard's ownership reported and who signed the filing?

The ownership is reported as of 03/31/2026 and signed on 04/29/2026. The Schedule 13G shows Ashley Grim, Head of Global Fund Administration, signed the submission on behalf of Vanguard Capital Management.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 06:26 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Encompass Health Corp

(Name of Issuer)

Common Stock

(Title of Class of Securities)

29261A100

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29261A100

1

Names of Reporting Persons

Vanguard Capital Management

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 767,385.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,233,622.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,233,622.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.26 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Encompass Health Corp
(b)	Address of issuer's principal executive offices: 9001 Liberty Pkwy, Birmingham, AL, 35242
Item 2.
(a)	Name of person filing: Vanguard Capital Management
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 29261A100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 5233622
(b)	Percent of class: 5.26 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 767385
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 5233622
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vanguard Capital Management

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	04/29/2026